This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tracy, R. P. Search for Related Content PubMed PubMed Citation Articles by Tracy, R. P. Related Collections Pathophysiology Risk Factors

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2002;22:1514.)
© 2002 American Heart Association, Inc.

Editorials

Inflammation in Cardiovascular Disease

Cart, Horse or Both–Revisited

Russell P. Tracy

From the Department of Pathology and Biochemistry, University of Vermont College of Medicine, Colchester.

Address correspondence to Dr Russell P. Tracy, Professor of Pathology and Biochemistry, University of Vermont College of Medicine, 208 South Park Dr, Ste 2, Colchester, VT 05446. E-mail Russell.tracy@uvm.edu

An extract of the first 250 words of the full text is provided, because this article has no abstract.

"We know that the tail must wag the dog, for the horse is drawn by the cart; but the Devil whoops, as he whooped of old: ‘It’s clever, but is it Art?’"¹

— (Rudyard Kipling, 1865–1936)

In 1998, I wrote an editorial that attempted to make two points.² The first point was biological: there existed at that time an active debate over whether inflammation was a cause or a result of cardiovascular disease (CVD), and I suggested that this debate was in fact based on a false distinction, and that both positions where likely to be correct. While atherothrombotic disease is inflammatory, inflammation mediators actually participate in the disease process. The second point was clinical: the routine use of a marker of inflammation in cardiovascular risk prediction was likely in the near future, since this dimension of vascular disease was important and relatively easy to capture with a blood test. C-reactive protein (CRP) seemed to be a good candidate for reasons that were not so much biological as technical and logistic.

See page 1668

Since that time, much of the debate over cause and effect has subsided and, to my reading at least, most articles addressing inflammation and CVD risk these days either directly or tacitly acknowledge both positions. In addition, CRP has become, if not an accepted component of CVD risk assessment, at least a commonly measured CVD risk factor.³ While this has been excellent progress, however, many questions remain both on the scientific front and on the clinical . . . [Full Text of this Article]

This article has been cited by other articles:

				L. J. Shaw, R. Bugiardini, and C. N. B. Merz Women and ischemic heart disease: evolving knowledge. J. Am. Coll. Cardiol., October 20, 2009; 54(17): 1561 - 1575. [Abstract] [Full Text] [PDF]

				W. Shu, W. Lei, and S. Peng Recent development of ischaemic heart disease in sex difference Postgrad. Med. J., April 1, 2007; 83(978): 240 - 243. [Abstract] [Full Text] [PDF]

				K. W.J. Lee, J. S. Hill, K. R. Walley, and J. J. Frohlich Relative value of multiple plasma biomarkers as risk factors for coronary artery disease and death in an angiography cohort. Can. Med. Assoc. J., February 14, 2006; 174(4): 461 - 466. [Abstract] [Full Text] [PDF]

				L. J. Shaw, C. N. Bairey Merz, C. J. Pepine, S. E. Reis, V. Bittner, S. F. Kelsey, M. Olson, B. D. Johnson, S. Mankad, B. L. Sharaf, et al. Insights From the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part I: Gender Differences in Traditional and Novel Risk Factors, Symptom Evaluation, and Gender-Optimized Diagnostic Strategies J. Am. Coll. Cardiol., February 7, 2006; 47(3_Suppl_S): S4 - S20. [Abstract] [Full Text] [PDF]

				E. M. Crimmins and C. E. Finch Infection, inflammation, height, and longevity PNAS, January 10, 2006; 103(2): 498 - 503. [Abstract] [Full Text] [PDF]